PTCT - PTC Therapeutics, Inc.

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
698,801
698,801
538,593
380,766
306,980
Cost of revenue
44,678
44,678
32,328
18,942
12,135
Gross profit
654,123
654,123
506,265
361,824
294,845
Operating expenses
Research development
651,496
651,496
540,684
477,643
257,452
Selling general and administrative
325,998
325,998
285,773
245,164
202,541
Total operating expenses
1,094,048
1,094,048
881,208
759,699
487,643
Operating income or loss
-439,925
-439,925
-374,943
-397,875
-192,798
Interest expense
90,871
90,871
86,022
56,352
-
Total other income/expenses net
-56,691
-56,691
-57,375
51,295
-34,637
Income before tax
-587,487
-587,487
-518,340
-402,932
-239,926
Income tax expense
-28,470
-28,470
5,561
35,228
11,650
Income from continuing operations
-559,017
-559,017
-523,901
-438,160
-251,576
Net income
-559,017
-559,017
-523,901
-438,160
-251,576
Net income available to common shareholders
-559,017
-559,017
-523,901
-438,160
-251,576
Basic EPS
-
-7.79
-7.43
-6.64
-4.27
Diluted EPS
-
-7.79
-7.43
-6.64
-4.27
Basic average shares
-
71,729
70,466
66,028
58,863
Diluted average shares
-
71,729
70,466
66,028
58,863
EBITDA
-
-380,062
-377,567
-261,708
-165,148